Clinical trial
Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast…
NCT00431106 · Hellenic Oncology Research Group, Other · Completed
Key facts
| NCT number | NCT00431106 |
|---|---|
| Title | Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast Cancer |
| Official title | A Multicenter Randomized Phase III Study of Combination Treatment With Vinorelbine and Gemcitabine Versus Capecitabine Monotherapy in Metastatic Breast Cancer Patients Following Treatment Failure With the Combination of a Taxane and an Anthracycline |
| Lead sponsor | Hellenic Oncology Research Group, Other |
| Collaborators | University Hospital of Crete |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine, Capecitabine, Vinorelbine |
| Enrollment | 144 |
| Start date | Apr 1, 2002 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Feb 5, 2007 |
| Last update posted | Sep 28, 2009 |
| Countries | Greece |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: